Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Societe Generale price target raised to EUR 16.80 from EUR 16.30 at Barclays » 15:07
01/22/21
01/22
15:07
01/22/21
15:07
SCGLY

Societe Generale

$0.00 /

+ (+0.00%)

Barclays analyst Omar…

Barclays analyst Omar Fall raised the firm's price target on Societe Generale to EUR 16.80 from EUR 16.30 and keeps an Underweight rating on the shares.

ShowHide Related Items >><<
SCGLY Societe Generale
$0.00 /

+ (+0.00%)

SCGLY Societe Generale
$0.00 /

+ (+0.00%)

01/14/21 Morgan Stanley
Societe Generale price target raised to EUR 18.30 from EUR 18 at Morgan Stanley
01/13/21 JPMorgan
Societe Generale price target raised to EUR 23 from EUR 22 at JPMorgan
12/10/20 Morgan Stanley
Societe Generale price target lowered to EUR 18 from EUR 19 at Morgan Stanley
12/09/20 UBS
Societe Generale price target raised to EUR 18 from EUR 16.50 at UBS
SCGLY Societe Generale
$0.00 /

+ (+0.00%)

Recommendations
SVB Financial price target raised to $550 from $440 at JPMorgan » 09:51
01/22/21
01/22
09:51
01/22/21
09:51
SIVB

SVB Financial

$495.01 /

+39.165 (+8.59%)

JPMorgan analyst Steven…

JPMorgan analyst Steven Alexopoulos raised the firm's price target on SVB Financial to $550 from $440 and keeps an Overweight rating on the shares. The company's Q4 results from "demonstrated yet again that this is the bank of the innovation economy," Alexopoulos tells investors in a research note. The analyst continues to see SVB as a "dominant player" in the regional banking industry which should see "years of continued outsized top and bottom line growth."

ShowHide Related Items >><<
SIVB SVB Financial
$495.01 /

+39.165 (+8.59%)

SIVB SVB Financial
$495.01 /

+39.165 (+8.59%)

01/22/21 RBC Capital
SVB Financial price target raised to $508 from $494 at RBC Capital
01/22/21 Wells Fargo
SVB Financial price target raised to $400 from $325 at Wells Fargo
01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
SIVB SVB Financial
$495.01 /

+39.165 (+8.59%)

SIVB SVB Financial
$495.01 /

+39.165 (+8.59%)

Recommendations
SVB Financial price target raised to $508 from $494 at RBC Capital » 08:36
01/22/21
01/22
08:36
01/22/21
08:36
SIVB

SVB Financial

$455.02 /

-7.49 (-1.62%)

RBC Capital analyst Jon…

RBC Capital analyst Jon Arfstrom raised the firm's price target on SVB Financial to $508 from $494 and keeps an Outperform rating on the shares. The company reported "favorable" core trends with its Q4 earnings beat that featured a very robust balance sheet growth and healthy fee income, the analyst tells investors in a research note.

ShowHide Related Items >><<
SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

01/22/21 Wells Fargo
SVB Financial price target raised to $400 from $325 at Wells Fargo
01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
01/05/21 Raymond James
SVB Financial price target raised to $440 from $325 at Raymond James
SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

Recommendations
SVB Financial price target raised to $400 from $325 at Wells Fargo » 07:01
01/22/21
01/22
07:01
01/22/21
07:01
SIVB

SVB Financial

/

+

Wells Fargo analyst Jared…

Wells Fargo analyst Jared Shaw raised the firm's price target on SVB Financial to $400 from $325 and keeps an Equal Weight rating on the shares. While Shaw continues to think there is downside risk, with shares trading at double the industry multiple, "you can't argue with results," he says. Growth in 2020 was "exceptional," and Shaw says the trends seem to be supported to continue into 2021.

ShowHide Related Items >><<
SIVB SVB Financial
/

+

SIVB SVB Financial
/

+

01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
01/05/21 Raymond James
SVB Financial price target raised to $440 from $325 at Raymond James
01/05/21 RBC Capital
SVB Financial price target raised to $437 from $320 at RBC Capital
SIVB SVB Financial
/

+

SIVB SVB Financial
/

+

Thursday
On The Fly
Fly Intel: After-Hours Movers » 18:35
01/21/21
01/21
18:35
01/21/21
18:35
SIVB

SVB Financial

$455.02 /

-7.49 (-1.62%)

, WAL

Western Alliance

$69.40 /

-1.92 (-2.69%)

, INDB

Independent Bank

$78.68 /

-1.39 (-1.74%)

, OZK

Bank OZK

$34.03 /

-0.59 (-1.70%)

, FLDM

Fluidigm

$6.17 /

+0.31 (+5.29%)

, MNOV

MediciNova

$5.78 /

+0.09 (+1.58%)

, SWIR

Sierra Wireless

$18.41 /

+0.02 (+0.11%)

, ALDX

Aldeyra

$11.77 /

-0.48 (-3.92%)

, AMRN

Amarin

$6.31 /

+0.11 (+1.78%)

, IBM

IBM

$131.80 /

+1.72 (+1.32%)

, STX

Seagate

$63.00 /

+1.57 (+2.56%)

, PPG

PPG

$143.94 /

-0.635 (-0.44%)

, ISRG

Intuitive Surgical

$799.43 /

-0.18 (-0.02%)

, CSX

CSX

$91.61 /

-1.6101 (-1.73%)

, PGEN

Precigen

$9.18 /

-0.22 (-2.34%)

, ACB

Aurora Cannabis

$11.17 /

-0.39 (-3.37%)

, F

Ford

$11.53 /

+0.665 (+6.12%)

Check out this evening's…

ShowHide Related Items >><<
SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
01/05/21 Raymond James
SVB Financial price target raised to $440 from $325 at Raymond James
01/05/21 RBC Capital
SVB Financial price target raised to $437 from $320 at RBC Capital
WAL Western Alliance
$69.40 /

-1.92 (-2.69%)

01/08/21 UBS
Western Alliance upgraded to Buy from Neutral at UBS
01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/15/20 Truist
Truist raises price targets on select regional banks
11/04/20 Stephens
Western Alliance resumed with an Overweight at Stephens
INDB Independent Bank
$78.68 /

-1.39 (-1.74%)

12/17/20 Seaport Global
Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys
12/17/20 Seaport Global
Independent Bank initiated with a Neutral at Seaport Global
10/26/20 Compass Point
Independent Bank upgraded to Buy from Neutral at Compass Point
06/24/20 Piper Sandler
Independent Bank downgraded to Neutral from Overweight at Piper Sandler
OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

06/17/20 Raymond James
Bank OZK upgraded to Outperform from Market Perform at Raymond James
06/17/20 Citi
Bank OZK downgraded to Neutral from Buy at Citi
06/17/20 Raymond James
Bank OZK upgraded to Outperform from Market Perform at Raymond James
04/28/20 Truist
Bank OZK price target raised to $22 from $19 at SunTrust
FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
10/19/20 Piper Sandler
Fluidigm test pact in Texas 'another validation,' says Piper Sandler
09/29/20 Piper Sandler
Piper Sandler would be buyers of Fluidigm given recent pullback
MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

01/14/21
Fly Intel: Top five analyst initiations
01/14/21 B. Riley Securities
Sierra Wireless initiated with a Buy at B. Riley Securities
11/25/20 Colliers
Sierra Wireless initiated with a Buy at Colliers
02/14/20 Roth Capital
Roth Capital sees upside in Sierra Wireless after 2020 transition year
ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

01/08/21 Jefferies
Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
01/08/21 Citi
Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
01/07/21 Alliance Global Partners
Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
12/16/20 Berenberg
Berenberg starts Aldeyra with Buy, sees near-term catalysts
AMRN Amarin
$6.31 /

+0.11 (+1.78%)

01/08/21 Piper Sandler
Piper sees 're-birth' for Amarin shares in 2021, keeps $19 price target
12/28/20 Cantor Fitzgerald
Vascepa showing positive year-over-year trends, says Cantor Fitzgerald
12/23/20 Goldman Sachs
Amarin price target lowered to $6 from $8 at Goldman Sachs
12/14/20 Piper Sandler
Amarin's Vascepa showed 'encouraging results' in Covid patients, says Piper
IBM IBM
$131.80 /

+1.72 (+1.32%)

10/20/20 Morgan Stanley
Morgan Stanley continues to view IBM as 'a 2022 stock'
10/20/20 Citi
IBM is 'getting even more complex,' says Citi
10/20/20 BMO Capital
IBM price target lowered to $138 from $140 at BMO Capital
10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
STX Seagate
$63.00 /

+1.57 (+2.56%)

01/21/21 Barclays
Seagate price target raised to $60 from $41 at Barclays
01/20/21 Wedbush
Seagate price target raised to $56 from $47 at Wedbush
01/19/21 Northland
Seagate price target raised to $72 from $65 at Northland
01/19/21 Loop Capital
Seagate price target raised to $70 from $60 at Loop Capital
PPG PPG
$143.94 /

-0.635 (-0.44%)

01/20/21 Citi
Citi adds PPG to US Focus List, removes FMC
01/14/21 Berenberg
PPG upgraded to Buy with $165 price target at Berenberg
01/14/21 Berenberg
PPG upgraded to Buy from Hold at Berenberg
12/01/20 Deutsche Bank
PPG price target raised to $165 from $155 at Deutsche Bank
ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

12/15/20 Morgan Stanley
Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley
12/15/20 Morgan Stanley
Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley
11/24/20 Raymond James
Intuitive Surgical not surprised by J&J robot features, says Raymond James
10/16/20 JPMorgan
Intuitive Surgical price target raised to $785 from $765 at JPMorgan
CSX CSX
$91.61 /

-1.6101 (-1.73%)

01/20/21 Susquehanna
Railroad recovery expected to continue in 2021, says Susquehanna
01/11/21 Citi
CSX price target raised to $105 from $87 at Citi
12/10/20 Morgan Stanley
Morgan Stanley downgrades CSX to Underweight with bar raised too high
12/10/20 Morgan Stanley
CSX downgraded to Underweight from Equal Weight at Morgan Stanley
PGEN Precigen
$9.18 /

-0.22 (-2.34%)

12/16/20 H.C. Wainwright
Precigen price target raised to $10 from $8 at H.C. Wainwright
05/08/20
Fly Intel: Top analyst initiations
05/08/20 H.C. Wainwright
Precigen initiated with a Buy at H.C. Wainwright
ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

01/06/21 BMO Capital
Federal cannabis reform in U.S. likely to take time, says BMO Capital
12/17/20 BMO Capital
Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
12/04/20 Alliance Global Partners
Alliance Global sees low odds of MORE Act passing this congressional session
12/02/20 Alliance Global Partners
Alliance Global Partners sees UN cannabis reclassification helping legalization
F Ford
$11.53 /

+0.665 (+6.12%)

01/20/21 Deutsche Bank
Ford price target raised to $11 from $9 at Deutsche Bank
01/20/21 Deutsche Bank
Ford named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/23/20 Morgan Stanley
Apple's potential EV entry represents 'new Tesla bear case,' says Morgan Stanley
WAL Western Alliance
$69.40 /

-1.92 (-2.69%)

SWIR Sierra Wireless
$18.41 /

+0.02 (+0.11%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

OZK Bank OZK
$34.03 /

-0.59 (-1.70%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

INDB Independent Bank
$78.68 /

-1.39 (-1.74%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ALDX Aldeyra
$11.77 /

-0.48 (-3.92%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

  • 22
    Jan
  • 22
    Jan
  • 14
    Jan
  • 11
    Nov
IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

SIVB SVB Financial
$455.02 /

-7.49 (-1.62%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

STX Seagate
$63.00 /

+1.57 (+2.56%)

PPG PPG
$143.94 /

-0.635 (-0.44%)

PGEN Precigen
$9.18 /

-0.22 (-2.34%)

MNOV MediciNova
$5.78 /

+0.09 (+1.58%)

ISRG Intuitive Surgical
$799.43 /

-0.18 (-0.02%)

IBM IBM
$131.80 /

+1.72 (+1.32%)

FLDM Fluidigm
$6.17 /

+0.31 (+5.29%)

F Ford
$11.53 /

+0.665 (+6.12%)

CSX CSX
$91.61 /

-1.6101 (-1.73%)

AMRN Amarin
$6.31 /

+0.11 (+1.78%)

ACB Aurora Cannabis
$11.17 /

-0.39 (-3.37%)

Earnings
SVB Financial reports Q4 EPS $7.40, consensus $3.83 » 16:12
01/21/21
01/21
16:12
01/21/21
16:12
SIVB

SVB Financial

$455.99 /

-6.52 (-1.41%)

Reports Q4 net interest…

Reports Q4 net interest margin 2.40% vs. 3.26% a year ago.

ShowHide Related Items >><<
SIVB SVB Financial
$455.99 /

-6.52 (-1.41%)

SIVB SVB Financial
$455.99 /

-6.52 (-1.41%)

01/08/21 Oppenheimer
Oppenheimer calls SVB Financial acquisition of Boston Private a 'good move'
01/05/21 DA Davidson
SVB Financial price target raised to $400 from $365 at DA Davidson
01/05/21 Raymond James
SVB Financial price target raised to $440 from $325 at Raymond James
01/05/21 RBC Capital
SVB Financial price target raised to $437 from $320 at RBC Capital
SIVB SVB Financial
$455.99 /

-6.52 (-1.41%)

SIVB SVB Financial
$455.99 /

-6.52 (-1.41%)

Recommendations
BNY Mellon price target raised to $49 from $43 at RBC Capital » 07:06
01/21/21
01/21
07:06
01/21/21
07:06
BK

BNY Mellon

$42.51 /

-3.3 (-7.20%)

RBC Capital analyst…

RBC Capital analyst Gerard Cassidy raised the firm's price target on BNY Mellon to $49 from $43 but keeps a Sector Perform rating on the shares. The analyst notes that the company has had to endure a low interest rate environment, which has driven down its net interest margin, increased money market fee waivers, and bloated its balance sheet over the last 12 months. Cassidy adds however that the Federal Reserve's action to lift the suspension of bank stock buybacks should enable the company to "unlatch the hatches" and start returning the excess capital to shareholders.

ShowHide Related Items >><<
BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

01/21/21 Citi
BNY Mellon earnings selloff a 'bit overdone,' says Citi
01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Piper Sandler
BNY Mellon price target raised to $47 from $40 at Piper Sandler
BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

Recommendations
BNY Mellon earnings selloff a 'bit overdone,' says Citi » 06:29
01/21/21
01/21
06:29
01/21/21
06:29
BK

BNY Mellon

$42.51 /

-3.3 (-7.20%)

Citi analyst Keith…

Citi analyst Keith Horowitz lowered the firm's price target on BNY Mellon to $55 from $57 and keeps a Buy rating on the shares. The post-earnings selloff in the shares "felt to be a bit overdone," Horowitz tells investors in a research note. While flat fee growth year-over-year is "tough to swallow" in context of expenses up 1.5%, excluding the fee waivers, fee growth should be up 3% year-over-year, meaning 150 basis points of positive fee leverage "which is a decent outlook," Horowitz tells investors in a research note.

ShowHide Related Items >><<
BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Citi
BNY Mellon upgraded to Buy from Neutral at Citi
01/11/21 Piper Sandler
BNY Mellon price target raised to $47 from $40 at Piper Sandler
01/05/21 Goldman Sachs
Northern Trust downgraded to Sell from Neutral at Goldman Sachs
BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

BK BNY Mellon
$42.51 /

-3.3 (-7.20%)

Wednesday
Recommendations
Erste Group Bank price target raised to EUR 28 from EUR 25 at JPMorgan » 11:58
01/20/21
01/20
11:58
01/20/21
11:58
EBKDY

Erste Group Bank

$0.00 /

+ (+0.00%)

JPMorgan analyst Samuel…

JPMorgan analyst Samuel Goodacre raised the firm's price target on Erste Group Bank to EUR 28 from EUR 25 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
EBKDY Erste Group Bank
$0.00 /

+ (+0.00%)

01/11/21 UBS
Erste Group Bank price target raised to EUR 29 from EUR 23 at UBS
10/29/20 UBS
Erste Group Bank price target lowered to EUR 23 from EUR 24.80 at UBS
10/23/20 Societe Generale
Erste Group Bank price target lowered to EUR 25 from EUR 26 at Societe Generale
10/21/20 Citi
Erste Group Bank price target lowered to EUR 25 from EUR 25.85 at Citi
Hot Stocks
Haemonetics acquires Cardiva Medical for over $475M » 06:50
01/20/21
01/20
06:50
01/20/21
06:50
HAE

Haemonetics

$128.35 /

+2.59 (+2.06%)

, MC

Moelis

$55.02 /

-0.17 (-0.31%)

, JPM

JPMorgan

$138.00 /

-0.84 (-0.61%)

Haemonetics announced…

Haemonetics announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an upfront cash payment of $475M at closing and up to an additional $35M in contingent consideration based on sales growth. The acquisition is subject to customary closing conditions and is expected to be completed in the Q1. Cardiva's portfolio includes two catheter-based vascular access site closure devices. The acquisition is expected to deliver about $65M-$75M of revenue in the first fiscal year. The transaction is expected to be dilutive to adjusted net earnings per diluted share by (15c)-(20c) in FY22 and about neutral to adjusted net earnings per diluted share in fiscal year 2023. The acquisition is expected to deliver a rate of return on invested capital of 10% by year five. Haemonetics plans to finance this acquisition through a combination of cash, existing revolving credit facility and an additional $150M term loan. Following this acquisition, the Company debt to EBITDA ratio, as calculated in accordance with the terms set forth in the Company's existing Credit Agreement, is expected to be approximately 3.2. Moelis & Company (MC) is serving as financial advisor to Haemonetics and DLA Piper is serving as legal advisor. Additionally, J.P. Morgan (JPM) Securities is acting as financial advisor to Cardiva and Cooley is serving as legal advisor.

ShowHide Related Items >><<
MC Moelis
$55.02 /

-0.17 (-0.31%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

HAE Haemonetics
$128.35 /

+2.59 (+2.06%)

HAE Haemonetics
$128.35 /

+2.59 (+2.06%)

11/05/20 Barrington
Haemonetics upgraded to Outperform from Market Perform at Barrington
07/01/20 Raymond James
Haemonetics price target lowered to $113 from $125 at Raymond James
05/06/20 Barrington
Haemonetics downgraded to Market Perform from Outperform at Barrington
04/07/20 Raymond James
Haemonetics price target lowered to $130 from $150 at Raymond James
MC Moelis
$55.02 /

-0.17 (-0.31%)

01/07/21 JPMorgan
Moelis upgraded to Neutral on M&A recovery at JPMorgan
01/07/21 JPMorgan
Moelis upgraded to Neutral from Underweight at JPMorgan
01/05/21 UBS
Moelis upgraded to Buy from Neutral at UBS
12/16/20 Seaport Global
Seaport Global starts Moelis at Neutral, cites value focus
JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

01/19/21 DA Davidson
JPMorgan price target raised to $163 from $147 at DA Davidson
01/19/21 Seaport Global
JPMorgan price target raised to $157 from $140 at Seaport Global
01/19/21 RBC Capital
JPMorgan price target raised to $150 from $130 at RBC Capital
01/19/21 Credit Suisse
JPMorgan price target raised to $150 from $142 at Credit Suisse
MC Moelis
$55.02 /

-0.17 (-0.31%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

HAE Haemonetics
$128.35 /

+2.59 (+2.06%)

  • 28
    Oct
JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

MC Moelis
$55.02 /

-0.17 (-0.31%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

JPM JPMorgan
$138.00 /

-0.84 (-0.61%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.